Decellularization of the Murine Cardiopulmonary Complex
May 30th, 2021
2.8K views
This protocol aims to decellularize the heart and lungs of mice. The resulting extracellular matrix (ECM) scaffolds can be immunostained and imaged to map the location and topology of their components.
Overview
This protocol details the decellularization of mouse heart and lungs to create extracellular matrix (ECM) scaffolds. These scaffolds can be immunostained and imaged for component mapping and analysis.
Key Study Components
Area of Science
- Neuroscience
- Biology
- Tissue Engineering
Background
- Decellularization preserves the structural integrity of tissues.
- ECM scaffolds are crucial for biochemical and anatomical studies.
- This method allows for detailed analysis at the sub-micron scale.
- Understanding ECM can lead to advancements in regenerative medicine.
Purpose of Study
- To develop a reliable protocol for creating ECM scaffolds from mouse organs.
- To facilitate the mapping of ECM components.
- To enable further biochemical and anatomical analysis of the ECM.
Methods Used
- Shaving the thorax, abdomen, and back of euthanized mice.
- Disinfecting the area with 70% ethanol.
- Decellularization process to extract ECM.
- Immunostaining and imaging techniques for analysis.
Main Results
- Successful extraction of ECM scaffolds from heart and lungs.
- Retention of structural integrity in the decellularized tissues.
- Mapping of ECM components achieved through imaging.
- Potential applications in regenerative medicine demonstrated.
Conclusions
- The protocol provides a robust method for ECM extraction.
- It opens avenues for detailed biochemical and anatomical studies.
- Future research can build upon these findings for therapeutic applications.
Frequently Asked Questions
What is decellularization?
Decellularization is the process of removing cellular components from tissues to create scaffolds that retain the extracellular matrix.
Why is the ECM important?
The ECM provides structural and biochemical support to surrounding cells and is crucial for tissue regeneration and repair.
What are the applications of ECM scaffolds?
ECM scaffolds can be used in regenerative medicine, tissue engineering, and studying cellular interactions.
How does immunostaining work?
Immunostaining uses antibodies to detect specific proteins in tissues, allowing visualization of ECM components.
What are the benefits of using mouse models?
Mouse models are widely used in research due to their genetic similarity to humans and the ability to manipulate their genetics.
Executive Industry Relevance
Decellularization of the murine cardiopulmonary complex enables high-resolution structural analysis of the extracellular matrix (ECM) in health and disease. This approach supports target validation by providing cell-free scaffolds that preserve native ECM topology and composition, facilitating mechanistic de-risking in cardiopulmonary disease models. The protocol allows for quantitative assessment of ECM remodeling, which is critical for predictive confidence in preclinical target selection and lead identification efforts.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Enables interrogation of therapeutic hypotheses by revealing ECM structural changes associated with fibrosis and cancer models.
- Operational Value: Provides reproducible, dimensionally stable scaffolds for consistent biochemical and anatomical analysis across experimental conditions.
Screening & Assay Development
- Scientific Value: Generates ECM scaffolds suitable for immunostaining and mass spectrometry to quantify structural protein expression and composition.
- Operational Value: Produces scaffolds with increased permeability and light penetrability, enabling submicron-resolution 3D imaging for high-content screening applications.
Translational & Preclinical Research
- Scientific Value: Supports disease-relevant system analysis by allowing comparison of ECM scaffolds from healthy and diseased murine tissues, including models of fibrosis and cancer.
- Operational Value: Facilitates mechanistic de-risking by linking ECM remodeling to pathophysiological processes, informing risk-adjusted advancement decisions.
Pipeline & Workflow Integration
The decellularization protocol fits within the discovery continuum from target validation through preclinical assessment, providing ECM scaffolds that serve as a disease-relevant system for evaluating target engagement and pathway modulation.
- Discovery Biology: Supports hypothesis testing and pathway clarification by enabling structural and compositional analysis of the ECM in cardiopulmonary disease models.
- Screening: Delivers quantitative outputs via immunostaining and imaging that allow teams to compare ECM changes across conditions.
- Analytics: Enables three-dimensional tiled imaging at submicron resolution, providing detailed morphological and topological data for comparative analysis.
- Translational Research: Connects discovery to preclinical continuity by using ECM scaffolds from diseased models to assess target-related ECM remodeling.
- Enterprise Reuse: Establishes a reusable capability for generating standardized ECM scaffolds across multiple projects and disease models.
Operational & Enterprise Impact
- Scientific Value: Predictive confidence through high-resolution mapping of ECM structure and composition, reducing mechanistic ambiguity in target validation.
- Operational Value: Standardization and reproducibility via a microsurgical perfusion protocol that yields scaffolds free of dimensional distortions.
- Strategic Value: Better go/no-go decisions by enabling early assessment of ECM-related pathophysiological changes in preclinical models.
- Portfolio Impact: Risk-adjusted prioritization based on quantitative ECM remodeling data linked to disease progression.
Implementation Considerations
- Requires expertise in microsurgical dissection, vessel ligation, and perfusion techniques to maintain ECM structural integrity.
- Dependent on perfusion pump systems, silicone tubing, and decellularizing agents (DOC and SDS) for effective decellularization.
- Necessitates standardized immunostaining and imaging protocols, including fluorescence microscopy and confocal analysis, for consistent ECM component mapping.
- Involves adaptation considerations when applying the protocol to different murine disease models, ensuring consistent decellularization efficiency.
- Limited by the need for meticulous microsurgical preparation to avoid tissue damage and ensure complete, uniform decellularization of the cardiopulmonary complex.
Biopharma FAQs
Why is structural ECM analysis important for target validation?
Structural ECM analysis reveals disease-associated remodeling that can inform target selection and mechanistic understanding. The decellularized scaffolds retain native ECM topology, enabling accurate assessment of changes in fibrosis and cancer models. This supports target validation by linking molecular targets to pathophysiological ECM alterations.
How does vessel isolation and ligation contribute to effective decellularization?
Microsurgical ligation of vessels prevents leakage of decellularizing agents during perfusion, ensuring uniform agent distribution. Proper isolation of the trachea and aorta allows for retrograde and anterograde perfusion of heart and lungs. This technique is essential for achieving complete and uniform decellularization while preserving ECM structure.
What quantitative measurements enable ECM remodeling assessment?
Immunostaining of structural ECM proteins followed by fluorescence imaging allows quantification of protein expression and localization. Three-dimensional tiled imaging at submicron resolution enables morphological and topological analysis of the ECM scaffolds. These measurements support comparative analysis between healthy and diseased tissues to assess remodeling.
Why are replication requirements important for cross-functional collaboration?
Replication ensures that ECM scaffolds are consistently generated across experiments, supporting reliable data sharing between discovery, preclinical, and translational teams. The protocol’s reproducibility in producing dimensionally stable scaffolds facilitates standardized analysis. This consistency is critical for aligning findings across functions and informing integrated decision-making.
What statistical analysis capabilities are required before implementing this protocol?
Teams require the ability to quantify immunostaining signal intensity and distribution across ECM scaffolds for comparative statistical analysis. Image analysis tools are needed to measure structural parameters such as fiber density, porosity, and permeability from 3D imaging data. These capabilities enable statistical comparison of ECM changes between experimental groups to support data-driven target validation decisions.
